About Us

VENUS is Unique

The Venous thromboEmbolism Network U.S. (VENUS) is the only collaborative clinical trial research network in the U.S. focused on venous thrombosis.

VENUS’s purpose is to initiate and implement collaborative, multi-institutional clinical trials and/or other scientific research projects focused on thrombotic disorders in the United States. VENUS members are individual physician-scientists employed at various academic medical or other non-commercial research institutions in the U.S.

Members are organized into committees based on their research focus. Each VENUS committee is charged with organizing collaborative, multi-institutional research projects, including clinical trials, and applying for grant funds to support proposed projects.

VENUS is supported by the Hemostasis & Thrombosis Research Society, Versiti, ASH Foundation, National Blood Clot Alliance, and Anticoagulation Forum.

VENUS Executive Committee

Lisa Baumann Kreuziger, MD, MS

Lisa Baumann Kreuziger, MD, MS

Lisa Baumann Kreuziger, MD, MS

Henny Billett, MD

Lisa Baumann Kreuziger, MD, MS

Rachel Rosovsky, MD, MPH

Lisa Baumann Kreuziger, MD, MS

Guy Young, MD

Disease Focus Committees

  • Cancer and Thrombosis
  • VTE Treatment and Anticoagulant Management
  • Pediatrics
  • Device Related Thrombosis
  • Women and Thrombosis

VENUS Participating Institutions

  • Arkansas Children’s Research Institute
  • Beth Israel Deaconess Medical Center
  • Children’s Hospital Los Angeles
  • Children’s Mercy
  • Children’s Minnesota Research Institute
  • Cleveland Clinic
  • Colorado University Anschutz
  • Emory University
  • Hackensack Meridian Health
  • Hemophilia Thrombosis Research Institute
  • Massachusetts General Hospital
  • Mayo Clinic
Venus Network

VENUS includes more than 128 investigators in 38+ states.

  • Montefiore Medical Center
  • Newark Beth Israel Medical Center
  • The Ohio State University
  • Oregon Health Sciences University
  • Rochester Regional Health
  • Rush University
  • Tulane University
  • University of Alabama at Birmingham
  • University of Iowa
  • University of Michigan
  • University of North Carolina
  • University of Utah
  • University of Vermont
  • Virginia Commonwealth University
  • Washington University
  • Weill Cornell Medicine

International Network of VENous Thromboembolism (INVENT)

VENUS is a member of the International Network of VENous Thromboembolism (INVENT) Clinical Research Networks. INVENT is an independent, not-for-profit network of academic research groups.

INVENT exists to promote international collaboration between academic research networks that conduct venous thromboembolism (VTE) related clinical research and to enhance the profile, science and impact of investigator-led VTE medical research.

Upcoming Events

International Society on Thrombosis and Haemostasis

World Thrombosis Day: October 13

World Thrombosis Day takes place each year on October 13, the birthday of Rudolf Virchow, a pioneer in the fields of pathophysiology and thrombosis. Its goal is to shine a light on the often overlooked and misunderstood condition of thrombosis.

ISTH Congress

In July of 2022, the International Society on Thrombosis and Haemostasis (ISTH) will reconvene for the ISTH 2022 Congress in London, England, U.K., at ExCeL London. It will be the most important international meeting of the year in the field of thrombosis and hemostasis. This is an exciting opportunity to build your professional network and learn from global experts that will be sharing ground-breaking research. Save the date on your calendar today and begin planning your attendance.